EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Serodiagnosis of candidiasis, aspergillosis, and cryptococcosis



Serodiagnosis of candidiasis, aspergillosis, and cryptococcosis



Clinical Infectious Diseases 14 Suppl 1: S11-S22



In this review the present understanding of serological techniques for the diagnosis of invasive candidosis, invasive aspergillosis and cryptococcosis, is summarized, with emphasis on clinical usefulness, unresolved problems and prospects for future research.

(PDF same-day service: $19.90)

Accession: 002219263

Download citation: RISBibTeXText

PMID: 1562681

DOI: 10.1093/clinids/14.Supplement_1.S11



Related references

Supplement 1. Focus on Fungal Infections: An Update on Diagnosis and Treatment || Serodiagnosis of Candidiasis, Aspergillosis, and Cryptococcosis. Clinical Infectious Diseases 14: S11-S22, 1992

Combination systemic antifungal therapy for cryptococcosis, candidiasis, and aspergillosis. Journal of Infectious Disease Pharmacotherapy 3(4): 61-83, 1999

Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice. ChemoTherapy 28(6): 461-479, 1982

Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. ChemoTherapy 33(5): 381-395, 1987

Evaluation of water soluble pneumocandin L-743,872 in mouse models of disseminated aspergillosis, candidiasis and cryptococcosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 36(0): 106, 1996

Epidemiology and laboratory diagnosis of domestic pulmonary mycoses (aspergillosis, mucormycosis, cryptococcosis and candidiasis). Praxis 54(39): 1118-1124, 1965

Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis. Antimicrobial Agents and ChemoTherapy 40(10): 2243-2247, 1996

Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. Antimicrobial Agents and ChemoTherapy 34(3): 448-454, 1990

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrobial Agents and ChemoTherapy 41(11): 2333-2338, 1997

Therapy of Systemic Mycoses: Candidiasis, Aspergillosis, Cryptococcosis. Role of Itraconazol. Symposium. Hamburg, 10 June 1994. Mycoses 37 Suppl 2: 1-82, 1994

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrobial Agents and ChemoTherapy 39(5): 1077-1081, 1995

Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Medical Weekly 146: W14281-W14281, 2016

Serodiagnosis of cryptococcosis. Nihon Rinsho. Japanese Journal of Clinical Medicine 48 Suppl: 388-390, 1990

Serodiagnosis of cryptococcosis. Japanese Journal of Medical Mycology 26(4): 276-283, 1985

Problems in serodiagnosis of cryptococcosis. Mycopathologia et Mycologia Applicata 36(3): 353-358, 1968